Dermatologicals in Canada

Dermatologicals in Canada

Dermatologicals is expected to register current value growth in Canada in 2024 following robust gains in 2023. Canadians have fully returned to pre-pandemic habits and lifestyles and the category has transitioned to the drivers that were predominating prior to the outbreak of COVID-19, including Canada’s ageing population, which is helping to drive growth in categories such as haemorrhoid treatments. Older Canadians are more prone to haemorrhoids due to the ageing process, which can lead to a we...

Euromonitor International's Dermatologicals in Canada report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.